title: A new checkpoint in the path to GVHD? How bedside-to-bench stem cell transplant studies can inform human GVHD biology.
authors: Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, U.S. National Institutes of Health, Bethesda, Maryland, USA barrettj@nhlbi.nih.gov.
authors: Austin John
authors: AJ
authors: Barrett
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D000073883:CX3C Chemokine Receptor 1; D054428:Chemokine CX3CL1 / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D019707:Receptors, Chemokine / Q000276:immunology*
chemical_list: D000073883:CX3C Chemokine Receptor 1; C515538:CX3CL1 protein, human; C095235:CX3CR1 protein, human; D054428:Chemokine CX3CL1; D019707:Receptors, Chemokine
references: Biol Blood Marrow Transplant. 2014 Nov;20(11):1861-4
references: 25017764
references: N Engl J Med. 2013 Aug 8;369(6):529-39
references: 23924003
references: J Leukoc Biol. 2015 Feb;97(2):227-35
references: 25420917